The 13th Product Selection & Pipeline Optimization for Generics 2020 is a conference focused on best tactics and techniques for positioning portfolios to achieve compliance and overcome the current regulatory unknowns in the generics industry.
Topics
- Strategic partnership and licensing agreements to maximize portfolio capacity and ROI
- Product selection framework to enhance performance in line with portfolio initiatives
- Portfolio management to ensure and maintain speed to market
- Pproduct rationalization process to predict product viability and success
- Keep pace with the fast-paced generics market to achieve a competitive advantage and market exclusivity
Who should Attend
Vice Presidents, Senior Vice Presidents, Senior Managers and Directors from generic and branded pharmaceutical companies and API companies responsible for:
- Business Development
- Portfolio and Project Management
- Intellectual Property / General Counsel
- Regulatory Affairs
- Biologics / Biosimilars
- Generics (development)
- Supply Chain
- Patents / Patent Litigation
- Quality
